Plasma YKL-40, a new biomarker for atrial fibrillation?
Open Access
- 2 May 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 11 (8) , 1032-1036
Abstract
The aim of this study was to determine changes in a new potential biomarker plasma YKL-40 in patients with atrial fibrillation (AF) before and after electrical cardioversion (CV). Plasma concentrations of YKL-40 were measured in 56 patients (mean age 65 years, range 34–84) with persistent AF (lasting mean 128 days, range 14–960), in 19 age-matched patients with permanent AF, and in 19 healthy subjects. The patients with persistent AF underwent CV. Plasma YKL-40 was measured prior to CV, and at follow-up after 24 h, 30 and 180 days. Patients with persistent AF had lower plasma YKL-40 than patients with permanent AF [70 µg/L (42–105)] vs. [138 µg/L (48–225)] ( P = 0.003), and higher levels than healthy subjects [41 µg/L (29–52)] ( P = 0.001). Patients ( n = 22) who were still in sinus rhythm (SR) at follow-up 30 days after CV had unchanged plasma YKL-40 compared with baseline levels. The baseline levels of YKL-40 were correlated to the levels of IL-6, but not to high sensitivity C-reactive protein. Patients with AF have significantly elevated levels of YKL-40. YKL-40 was not a significant predictor of successful CV to SR. Plasma levels of YKL-40 did not fall after restoration of SR.Keywords
This publication has 25 references indexed in Scilit:
- YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of AlbuminuriaDiabetes Care, 2009
- Prognostic impact of hs‐CRP and IL‐6 in patients with persistent atrial fibrillation treated with electrical cardioversionScandinavian Journal of Clinical and Laboratory Investigation, 2009
- Plasma YKL-40Diabetes, 2008
- YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery diseaseScandinavian Cardiovascular Journal, 2008
- Experimental anti‐angiogenesis causes upregulation of genes associated with poor survival in glioblastomaInternational Journal of Cancer, 2007
- High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortalityClinical and Experimental Immunology, 2007
- A Chitinase-like Protein in the Lung and Circulation of Patients with Severe AsthmaNew England Journal of Medicine, 2007
- Serum YKL-40 levels in patients with coronary artery diseaseCoronary Artery Disease, 2007
- High-sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversionInternational Journal of Cardiology, 2006
- Regulation of YKL‐40 expression during genotoxic or microenvironmental stress in human glioblastoma cellsCancer Science, 2005